# Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

> **NCT05908669** · — · ENROLLING_BY_INVITATION · sponsor: **University of Aarhus** · enrollment: 10 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DIAGNOSTIC_TEST:** Deuterium metabolic imaging

## Key facts

- **NCT ID:** NCT05908669
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-08-25
- **Primary completion:** 2024-08-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05908669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05908669, "Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05908669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*